SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-23-005261
Filing Date
2023-08-11
Accepted
2023-08-11 11:18:47
Documents
44
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20230630_10q.htm   iXBRL 10-Q 729280
2 EXHIBIT 31.1 ex_553882.htm EX-31.1 9698
3 EXHIBIT 31.2 ex_553883.htm EX-31.2 9680
4 EXHIBIT 32.1 ex_553884.htm EX-32.1 5683
  Complete submission text file 0001171843-23-005261.txt   3319431

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20230630.xsd EX-101.SCH 25745
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20230630_cal.xml EX-101.CAL 27056
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20230630_def.xml EX-101.DEF 192735
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20230630_lab.xml EX-101.LAB 183711
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20230630_pre.xml EX-101.PRE 209959
38 EXTRACTED XBRL INSTANCE DOCUMENT xbit20230630_10q_htm.xml XML 438261
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 231162228
SIC: 2834 Pharmaceutical Preparations